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Abstract
AIM
To prospectively evaluate the postoperative morbi-
mortality and weight loss evolution of patients who 
underwent a laparoscopic sleeve gastrectomy (LSG) as a 
primary bariatric procedure during 5 years of follow-up. 
METHODS
Since 2006, data from patients undergoing a highly re-
strictive primary LSG have been prospectively registered 
in a database and analysed. Preoperative co-morbid 
conditions, operating time, hospital stay, early and late 
complications rate and evolution of weight loss after 5 
years of follow-up were analysed.
RESULTS
A total of 156 patients were included, 74.3% of whom 
were women. The mean age was 43.2 ± 13.1 years and 
the mean body mass index (BMI) was 41.5 ± 7.9 kg/m2. 
Seventy patients (44.8%) presented a BMI under 40 
kg/m2. The mortality rate was 0%. The leakage rate was 
1.2%, and the total 30-d morbidity rate was 5.1% (8/156). 
With a mean follow-up of 32.7 ± 28.5 (range 6-112) 
mo, the mean percent of excess of weight loss (%EWL) 
was 82.0 ± 18.8 at 1 year, 76.7 ± 21.3 at 3 years and 
60.3 ± 28.9 at 5 years. The mean percent of excess of 
BMI loss (%EBMIL) was 94.9 ± 22.4 at 1 year, 89.4 ± 
27.4 at 3 years and 74.8 ± 29.4 at 5 years. Patients with 
preoperative BMI less than 40 kg/m2 achieved greater 
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weight loss than did the overall study population. Diabetes 
remitted in 75% of the patients and HTA improved in 
71.7%. CPAP masks were withdrawn in all patients with 
obstructive sleep apnoea.
CONCLUSION
LSG built with a narrow 34 F bougie and starting 3 cm 
from the pylorus proved to be safe and highly effective 
in terms of weight loss as a stand-alone procedure, 
particularly in patients with a preoperative BMI lower than 
40 kg/m2.
Key words: Sleeve gastrectomy; Morbid obesity; Bariatric 
surgery; Obesity surgery; Laparoscopy; Long-term results; 
5-year results
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: The number of laparoscopic sleeve gastrectomies 
(LSGs) performed worldwide as a primary bariatric 
procedure has grown exponentially in recent years, given 
the simplicity of the technique, the low complication 
rate and the good short- and mid-term results regarding 
weight loss and the resolution of co-morbidities. However, 
there are a limited data from long-term studies. In this 
study, a standardized LSG proved to be safe (no mortality 
and a leakage rate of 1.2%) and highly effective in terms 
of weight loss after 5-year of follow-up, particularly in 
patients with a low preoperative body mass index. This 
manuscript provides additional evidence supporting the 
role of laparoscopic sleeve gastrectomy as a stand-alone 
procedure for selected morbidly obese patients. 
Hoyuela C. Five-year outcomes of laparoscopic sleeve gastrectomy 
as a primary procedure for morbid obesity: A prospective study. 




The laparoscopic bariatric procedure commonly referred 
to as “sleeve gastrectomy” (LSG) is a left partial gas­
trectomy of the fundus and body to create a long tubular 
gastric conduit constructed along the lesser curve of the 
stomach[1]. 
LSG was initially proposed as a first-stage procedure 
to reduce the mortality and postoperative morbidity 
of more complex bariatric procedures in higher­risk 
patients[2], such as the duodenal switch, to complete the 
biliopancreatic diversion or the Roux­en­Y gastric bypass 
(RYGB) in a second stage. Soon, it was noted that many 
patients frequently lost sufficient weight such that a 
second­stage operation became unnecessary[3]. LSG is 
not merely a restrictive procedure. LSG provokes a rapid 
gastric emptying of solid food, accelerates intestinal transit 
and induces a favourable change in the gut hormones, 
thereby facilitating weight loss through restriction and 
appetite suppression, given the reduction in the ghrelin 
levels after resection of the gastric fundus[3­7]. Since then, 
LSG has been performed as a primary and definitive 
bariatric procedure in patients whose weight and medical 
condition are not sufficiently severe to require a complex 
bariatric operation, moving to a second stage only in those 
selected patients in which weight loss was inadequate[8]. 
Eventually, LSG was performed in some patients with 
special conditions in which the usual bariatric operations 
might be too aggressive[9]. 
The number of LSGs performed worldwide has grown 
exponentially over the last decade, because it appears 
to be an easier and safer technique[10­13]. Many surgeons 
now perform LSG as their standard bariatric operation[3]. 
The advantages of the LSG include its technical sim­
plicity, shorter operative time, maintenance of bowel 
integrity and preservation of the pylorus[3,10]. The long­
term problems associated with other complex bariatric 
procedures, including internal hernias and small bowel 
obstruction are avoided with LSG. In addition, patients 
who underwent LSG had fewer nutritional deficiencies 
than that did patients who underwent RYGB or bilio­
pancreatic diversion[14]. The LSG can later be modified by 
a laparoscopic approach if required, to a more complex 
procedure (such as RYGB or duodenal switch) in patients 
who develop severe gastroesophageal reflux symptoms or 
those who regain weight.
LSG has proven highly effective at achieving durable 
weight loss and co­morbidity reduction over the short and 
intermediate terms and is comparable in some aspects to 
RYGB, the current gold standard in bariatric surgery[7,15­18]. 
However, some questions must be answered regarding 
the long­term results of LSG because there are a limited 
data from long­term studies and because of the variability 
in both the reported follow­up among series and the rate 
of patients lost to follow­up.
The aim of this study was to assess the safety and 
outcomes of patients who underwent a LSG as a primary 
bariatric procedure in analysing mortality, postoperative 
morbidity rate, late complications and evolution of weight 
loss after 5 years of follow­up.
MATERIALS AND METHODS 
Patients selection and study design
From 2006 to January 2016, data from patients who 
underwent a LSG as a single procedure treating morbid 
obesity were collected in an electronic database (Microsoft 
Access 2003 Microsoft Corporation, Redmond, QA, 
United States) for analysis. All study participants, or their 
legal guardian, provided informed written consent prior 
to study enrolment. The study was officially registered 
under the identification number researchregistry 1580 on 
researchregistry.com.
The indications for LSG included patients with 
body mass index (BMI) less than 45 kg/m2, primary 
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procedure in super­obese patients as the initial stage 
of a two­staged approach for weight loss (RYGB or BPD 
in 2 stages), adolescents (under 18 years old of age) 
with morbid obesity and obese patients with impaired 
medical conditions or other important co­morbidities 
such as liver cirrhosis.
The first endpoint of this study was to assess the safety 
of the procedure by analysing the 30­d mortality and early 
postoperative complications: Suture leak rate, haemorrhages, 
wound infection rate, deep venous thrombosis, pulmonary 
embolism and cardiac and pulmonary complications.
The second endpoint was to evaluate the outcome of 
LSG in terms of weight loss 5 years after the procedure. 
Weight loss was measured using BMI evolution and the 
percentage of excess weight loss (%EWL). Given the 
variability of %EWL depending on the definition of ideal 
body weight, we also used the percentage of excess 
body mass index loss (%EBMIL)[19]. Excessive BMI itself 
was defined as initial BMI minus 25. Values are reported 
as the mean ± standard deviation.
The following variables were also evaluated: Reso­
lution of preoperative co­morbid conditions [diabetes, 
hypertension, obstructive sleep apnoea syndrome (OSA)], 
length of hospital stay and late complications (stricture, 
functional obstruction, gastroesophageal reflux, trocar­
site hernia rate).
Surgical technique
Under general anaesthesia the patients were placed in 
the reverse Trendelenburg position with the surgeon 
standing between the legs. All patients received intra­
venous antibiotic prophylaxis with 2 g of cefazoline. Com­
pression stockings were used during the operation to 
prevent deep vein thrombosis and thromboembolism.
The procedure was performed using 4 or 5 ports (two 
or three 12­mm trocars and two 5­mm trocars). The 
greater curvature of the stomach was completely freed 
starting from the antrum (3 cm proximal to pylorus) until 
the left pillar of the diaphragm and the gastroesophageal 
junction were completely exposed. If a hiatal hernia 
is identified, dissection should be carried posteriorly 
to achieve appropriate closure of the crus. If a hernia 
is found, it should be repaired[10]. A harmonic scalpel 
(Ultracision®, Ethicon Endo­Surgery Inc., Johnson and 
Johnson, Cincinnati, OH, United States) was used to divide 
the gastroepiploic and the short gastric vessels. Then, 
the adhesions of the posterior side of the stomach were 
dissected to achieve an appropriate sleeved stomach. The 
LSG was performed by sequentially firing an articulating 
linear stapler (Echelon Flex™ Endopath, Ethicon Endo­
Surgery Inc., Johnson and Johnson, Cincinnati, OH, United 
States). The gastric division started at 3 cm proximal to 
the pylorus. Two 60­mm green staple cartridges (open 
height = 4.1 mm) were usually used to transect the 
antrum, and gold (3.8 mm) and blue loads (3.6 mm) were 
later applied at the gastric corpus and fundus. The whole 
fundus had to be removed. Special attention was required 
at that point to avoid rotation and functional obstruction of 
the sleeve by ensuring equal (and not excessive) traction 
on both walls of the stomach. It is of utmost importance 
to align the stapler firings properly to avoid excessive 
narrowing, especially at the level of the incisura angularis 
(Figure 1). 
The calibration of the LSG was obtained using a 34 F 
oral gastric tube (1.13 cm). The gastric stapled line was 
always oversewn with a 2/0 absorbable running suture 
(Monoplus®, B. Braun, Melsungen, Germany) in the 125 
initial cases. A bovine pericardial strip (BPS­Peristrip) was 
used in 5 patients. Since 2014, bioabsorbable membranes 
(Gore Seamguard® from WL Gore and  Associates, Newark, 
DE, United States) were used instead of the reinforcement 
suture to achieve better hemostasis and reduce the 
suture leakage rate[15]. Intraoperative leak testing using 
methylene blue dye was routinely performed. A suction 
Blake or Jackson­Pratt drain was placed along the suture 
line. Finally, the gastric specimen was withdrawn through 
the right 12­mm port. All 12­mm wounds were closed 
with Monoplus® or Monomax® 2/0 sutures (B. Braun, Mel­
sungen, Germany) using an Endoclose™ trocar­site closure 
device (Covidien Products, Medtronic, Minneapolis, MN, 
United States).
Patients started to walk 8 to 12 h after the procedure. 
A liquid diet was initiated on the first postoperative day 
and was implemented for two weeks. The patients were 
usually discharged on the second or third postoperative 
day. The treatment included oral analgesia, proton­pump 
inhibitors (PPI) and low molecular weight heparin against 
deep vein thrombosis for 30 d. 
Postoperative follow-up
The first follow-up control was scheduled at the medical 
office eight days after the procedure. Follow-up data were 
obtained at the medical office after 15 d, 1, 3, 6 mo, 1 
year and semi­annually thereafter by the surgeon who 
performed the procedure and by a nutritionist. All data 
were prospectively collected.
RESULTS
Data from 156 patients who underwent LSG until January 
2016 were analysed. Of the patients, 116 (74.4%) were 
Figure 1  Specimen after sleeve gastrectomy. The whole fundus had to be 
removed. Stapler firings must be properly aligned to avoid excessive narrowing 
of the sleeve and functional obstruction due to rotation. 
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Table 2  Mortality, early and late complications after laparoscopic 
sleeve gastrectomy n (%)
women, and 40 (25.6%) were men; overall, the mean 
age was 43.2 ± 13.1 (range 16­71) years, and the mean 
BMI was 41.5 ± 7.9 (range 34­76) kg/m2. Seventy 
patients (44.9%) presented BMI under 40 kg/m2, and 
only 15 patients (9.6%) were super­obese (BMI greater 
than 50 kg/m2). All the procedures were performed 
laparoscopically by the same surgeon. The mean hospital 
stay was 3.5 ± 0.7 d (range: 1­18). All patients completed 
the 6-mo outpatient follow-up at the medical office. The 
mean follow­up was 32.7 ± 28.5 mo (Table 1).
The mean operating time was 95 ± 14.1 min. Con­
version to laparotomy was necessary in 2 patients (1.2%) 
due to intraoperative haemorrhage. One patient was a 
woman suffering from a cavernous transformation of the 
portal vein and the other required a lateral segmentectomy 
to remove a bleeding 8­cm liver haemangioma.
Morbidity and mortality
No mortality was observed in this series. The total 
30­d postoperative complication rate was 5.1% (8/156 
patients). The type and severity of complications are listed 
in Table 2. A leakage in the staple­line was detected in 2 
women (1.2%). The first woman (after oversewing the 
staple line) healed successfully with medical management 
14 d after. The second (Peristrips® reinforcement) required 
a laparoscopic reoperation to drain a subphrenic abscess 
secondary to a leak at the angle of His. No endoprosthesis 
or self­expanded wall­stent was needed. There was no 
relationship between leakage and patients’ BMI, age 
or technical difficulties during the sleeve gastrectomy 
procedure. Intraoperative leak testing was not predictive 
of the later development of staple line leaks. No patients 
presented with deep vein thrombosis or pulmonary 
embolism.
Regarding late complications, one patient (without 
symptoms of previous staple­line leak) developed a 
gastric stricture 10 mo after the LSG and submitted to a 
laparoscopic gastric bypass (0.6%). Twenty­four patients 
(15.3%) referred to new­onset symptoms suggesting 
gastroesophageal reflux requiring daily low-dose of PPI. 
One of these patients developed a hiatal hernia and 
underwent laparoscopic hiatoplasty and a Hill gastropexy 
with good outcomes. To date, three patients (1.9%) have 
developed a trocar­site hernia. Cholecystectomy due to 
symptomatic gallstones was performed during the follow­
up in 7 patients (4.4%); 2 of them presented with acute 
pancreatitis. There were no data on the cholelithiasis rate 
in asymptomatic patients.
Weight loss
The mean follow­up was 32.7 ± 28.5 mo (range 6­112). 
There were 140 patients with at least 1 year of follow­
up. Fifty­one patients reached more than 5 years of 
follow­up.
The mean initial BMI was 41.5 ± 7.9 kg/m2 (range 
34.2­76.0), and the mean initial percentage of excess of 
weight (%EW) was 83.1% ± 18.1%. The preoperative 
BMI of 72 patients (44.9%) was less than 40 kg/m2. 
Marked weight loss was observed during the first year in 
all patients, achieving a mean BMI of 26.4 kg/m2, with 
a mean %EWL of 82.0 ± 18.8 and a mean %EBMIL 
of 94.9 ± 22.4 after the 1­year follow­up. However, 
weight loss dropped progressively during the follow­up 
with remarkable differences among the patients (Figure 
2). The mean %EBMIL was 89.4 ± 27.4 at 3 years 
and 74.8 ± 29.4 (range: 27.2­119.0) at 5 years. The 
evolution of mean BMI, %EWL and %EBMIL at different 
follow­up points is shown in Figure 2 and Table 3. 
The overall success rate, defined when %EWL is > 
50%, was 96.1% of the patients after 1 year, 95.1% 
after 2 years, 89.5% after 3 years, 82.1% after 4 years 
and 73.0% after 5 years. It must be highlighted that the 
patients with a lower initial BMI, especially those with 
initial BMI under 40 kg/m2, achieve excellent results in 
terms of %EWL and %EBMIL (Figure 3).
Revisional surgery
During postoperative follow­up, re­operation because 
of weight regain from %EWL > 50% to %EWL < 30% 
was necessary in 4 patients (2.5%), all of them beyond 
Table 1  Patients’ characteristics and general data of the series
Number of patients 156
Age1 (yr) 43.2 ± 13.2 (16-71)
Gender (Female/male) 116 / 40
BMI1 (kg/m2) 41.5 ± 7.9
BMI < 40 kg/m2 70 (44.9)
BMI 40-50 kg/m2 71 (45.5)
BMI > 50 kg/m2 15 (9.6)
Comorbidity
  HTA 39 (25)
  Diabetes 12 (7.6)
  Obstructive sleep apnea (with CPAP) 21 (13.4)
  Other 67 (42.9)
Operating time1 (min) 95 ± 14.1 (65-155)
Hospital stay1 (d) 3.5 ± 0.7 (1-18)
Follow-up1 (mo) 32.7 ± 28.5 (6-112)
1Data are frequency counts (percentage of total) or the mean ± SD plus 
range in parentheses. BMI: Body mass index; HTA: Arterial hypertension; 
CPAP: Continuous positive airway pressure.
Mortality 0
Total 30-d complications 8 (5.1)
Staple line leakage 2 (1.2)
Staple line haemorrhage 1 (0.6)
  Wound infection 2 (1.2)
  Pneumonia 1 (0.6)
  Cutaneous rash 1 (0.6)
  Urethral bleeding 1 (0.6)
Late complications
  Symptomatic gastroesophageal reflux 24 (15.3)
  Hiatal hernia needing laparoscopic repair 1 (0.6)
  Gastric stricture – conversion to gastric by-pass 1 (0.6)
  Symptomatic cholelithiasis 7 (4.4)
Data are frequency counts (percentage of total).
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the fourth year of follow­up. A 70­year­old woman re­
ceived a laparoscopic re­sleeve, one patient underwent a 
SADI’s and two received a laparoscopic RYGB. 
Resolution of co-morbidities
After the first postoperative year, the rate of remission 
or improvement of hypertension was 71.7% (total 
remission in 25 patients and improvement in 3). CPAP 
was withdrawn in all patients with obstructive sleep 
apnoea (OSA). Complete remission of type 2 diabetes 
(T2DM) was observed in 75% (9/12) of preoperative 
diabetic patients (remission was considered when anti­
diabetic medication was discontinued and blood glucose 
level was under 120 mg/mL). One patient receiving 
preoperative insulin improved and now receives per­oral 
anti­diabetic medication.
DISCUSSION
The first endpoint of this study was to assess the safety 
of LSG as a primary bariatric procedure. LSG has gained 
popularity in recent years given its theoretical technical 
simplicity and low rate of complications[10,11,15]. However, 
LSG can be a very difficult procedure even for laparoscopic 
surgeons with advanced skills. The surgeon’s experience 
and some technical aspects, such as the bougie size (less 
than 40 F) and the distance to the pylorus being less than 
4 cm from the first stapling, have been previously reported 
as risk factors for the development of complications after a 
LSG[13].
The mortality rate in this series was nil and the rate of 
30­d severe complications related to the procedure was 
1.9% (Table 1). The rate of staple­line leak and fistula, 
which is the most feared postoperative complication after 
LSG, was low in this series (1.2%), even when using a 
thin bougie to calibrate the stomach and sectioning the 
stomach at a short distance from the pylorus. According 
to the International Sleeve Gastrectomy Expert Panel[10], 
the average leak rate is 1.06% ± 1.13%. There is 
currently no consensus on the most effective measures 
to prevent the leakage and fistula, but we share the 
concept that reinforcing the staple line (with sutures 
or buttressing material) during LSG can significantly 
reduce the leakage rate[7,15,20]. The method for doing so 
is still a matter of debate[21]. Some reports showed no 
differences between oversewing of the staple line and 
the use of buttresses[22­24]. However, a systematic review 
of 88 included studies representing 8920 patients[15] 
found that the leak rate in LSG was significantly lower 
using absorbable membrane (Seamguard®) staple­line 
reinforcement (1.1%) than was oversewing (2.0%), 
bovine pericardial strip (BPS­Peristrips®) reinforcement 
(3.3%), or no reinforcement (2.6%). We observed one 
leak after oversewing of the staple line and another after 
the use of Peristrips®. No leaks were observed in the 
Seamguard® subgroup but the small number of patients 
in this series does not allow further analysis. It must be 
noted that the significantly highest incidence of leaks was 
reported when using both sutures and buttressing material 
(3.6%); consequently, this approach should always be 
avoided[24].
The second endpoint was to evaluate the evolution of 
weight loss after LSG as a primary bariatric procedure. 
The overall results of this study reinforce the evidence 
that LSG was effective at achieving a significant weight 
loss over short­ and mid­term follow­up. Comparable 
outcomes in terms of weight loss over a 5­year period 
were reported at the 3rd International Summit of Sleeve 
Gastrectomy[3], with a mean percentage of excess weight 
loss of 62.7%, 64.7%, 64.0%, 57.3%, and 60.0% after 
1, 2, 3, 4, and 5 years, respectively. These data are all 
consistent with other studies published to date[16,25­38] 
(Table 4). LSG outcomes are comparable to the gold 
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Figure 2  Evolution of body mass index, excess weight loss and excess 
body mass index loss during the follow-up. BMI: Body mass index; %EWL: 
Percent of excess weight loss; %EBMIL: Percent of excess body mass index 
loss.
Table 3  Weight loss results of laparoscopic sleeve gastrectomy over time
Follow-up Preoperative 1 yr 2 yr 3 yr 4 yr 5 yr
n 156 140 99 66 56 51
BMI1 41.5 ± 7.9 26.6 ± 4.4 26.3 ± 3.7 27.2 ± 5.8 28.7 ± 5.5 30.1 ± 6.1
%EWL1 82.0 ± 18.8 86.1 ± 28.9 76.7 ± 21.3 72.8 ± 22.6 60.3 ± 28.9
%EBMIL1 94.9 ± 22.4 93.7 ± 23.5 89.4 ± 27.4 81.1 ± 28.3 74.8 ± 29.4
1Data are frequency counts (total) or the mean ± SD. BMI: Body mass index; %EWL: Percentage of excess weight loss; %EBMIL: Percentage of excess body 
mass index loss. 
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supporting the role of LSG as a stand­alone bariatric 
operation for morbid obesity.
However, a significant amount of patients may regain 
weight over time after LSG. Long­term results of LSG still 
are an ongoing concern, and 10­year follow­up data are 
actually scarce. Furthermore, a high rate of patients lost 
to long­term follow­up is not uncommon in previously 
reported series. Although weight regain was evident 
with time, data from our series and some long­term 
observational studies indicate that a significant number 
of patients maintained good weight loss beyond 5 years 
of follow­up (Table 4). A recent systematic review of 16 
long­term studies including 492 patients revealed the 
%EWL to be 62.3%, 53.8%, 43% and 54.8% at 5, 6, 7 
and 8 or more years of follow­up, respectively[25]. Arman 
et al[39] reported a mean %EBMIL of 62.5% in patients 
who kept the simple sleeve construction (74.6% overall­
study series) after a mean follow­up of 11.7 years.
It is still unclear why LSG ceases to be effective over 
time in terms of weight loss in some patients, but several 
reasons could be involved, including dilation of the gastric 
tube, insufficient gastric fundus resection (where ghrelin 
is produced) or hyperactivity of previously silent ghrelin­
producing cells and other hormonal changes[6,26,39,40]. 
Inadequate adherence to aftercare changes in eating 
behaviour and lack of physical activity could play a role 
of paramount importance in patients with poorer main­
tenance of weight loss. A recent systematic review by 
Karmali et al[41] concluded that the underlying causes 
leading to weight regain are multi­factorial and related to 
patient- and procedure-specific factors.
Our data showed better results regarding weight loss 
when the initial BMI was lower. Patients with an initial 
BMI less than 40 kg/m2 registered excellent results (73% 
of EWL and 90.8% of EBMIL at 5 years) compared with 
the overall study population (Figure 3). Age > 60 years, 
pre­existing co­morbidities and BMI superior to 50 kg/m2 
were identified as prognostic factors of poorer outcome 
after LSG. Super­obese patients also had poorer weight 
loss results in this series. These results allow us to 
suggest that LSG could be routinely used as a sole 
bariatric technique for patients whose BMI was less than 
Figure 3  Excess weight loss evolution and excess body mass index loss evolution according to preoperative body mass index. Patients with a preoperative 
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Table 4  Long-term weight loss outcome of laparoscopic sleeve gastrectomy for morbid obesity
Author Year Patients with 5-yr follow-up Mean initial BMI (kg/m2) %EWL 1 yr %EWL 5 yr %EBMIL 1 yr %EBMIL 5 yr
Bohdjalian[26] 2010 26 48.2 ± 1.3 57.5 ± 4.5 55.0 ± 6.8
Himpens[27] 2010 30 39 53.3
D’Hondt[28] 2011 83 39.3 78.5 54.4
Braghetto[29] 2012 60 38.4 ± 5.1 57.3 57.3
Sarela[30] 2012 13 45.9 76 69 (8 yr)
Rawlins[31] 2013 49 65 56 85.8 91
Sieber[32] 2014 62 43.0 ± 8.0 61.5 ± 23.4 57.4 ± 24.7
Boza[33] 2014 112 34.9 88 62.9
Liu[34] 2015 44 41.0 ± 7.0 70.5 57.2
Lemanu[35] 2015 55 50.7 56 40
Pok[36] 2015 61 37.3 ± 8.1 76.5 72.6
Alexandrou[37] 2015 30 55.5 ± 1.7 65.2 ± 6.1 56.4 ± 5.8
Perrone[38] 2016 162 47.4 ± 4.2 75.1 ± 18.9 78.8 ± 23.5
Hoyuela 2016 51 41.5 ± 7.9 82.0 ± 18.8 60.3 ± 28.9 94.9 ± 22.4 74.8 ± 29.4
BMI: Body mass index; %EWL: Percentage of excess weight loss; %EBMIL: Percentage of excess body mass index loss.
Hoyuela C. LSG as primary procedure for morbid obesity
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40 kg/m2. 
However, we observed high variability among patients 
regarding weight loss maintenance over time, even in 
patients with similar characteristics. No other significant 
differences were found between subgroups of patients 
probably due to the small sample of patients with 5 years 
of follow­up. Identifying preoperative predictive factors 
of success might be useful for developing strategies to 
improve bariatric surgery outcomes and patient selection. 
Further long­term follow­up randomized studies that 
include a larger number of patients are needed to identify 
which patients would benefit the most from LSG. 
The last endpoint was to analyse the resolution of 
preoperative co­morbidities in the patients who underwent 
a LSG. LSG allowed CPAP to be withdrawn in all patients 
in the series with preoperative OSA and achieved the 
resolution of hypertension and T2DM in more than 70%. 
The improvement of T2DM occurred soon after surgery, 
even without significant weight loss yet being achieved, 
and this fact could be attributed to hormonal changes, 
such as increased GLP­1 secretion or decreased ghrelin[6]. 
The long­term effects of LSG on T2DM evolution are 
under continuous evaluation, and Aminian et al[42] recently 
reported a 44% of long­term relapse of T2DM after initial 
remission and continuous complete remission for ≥ 5 
years (“cure”) was achieved in only 3% of the patients. 
LSG and RYGB showed comparable remission rates of 
T2DM in a long­term observational study[18], but a meta­
analysis including 6526 patients confirmed that RYGB 
achieved a higher diabetes remission rate (HR = 1.49, 
95%CI: 1.04­2.12)[16]. Current data suggesting the long­
term superiority of RYGB over LSG in the metabolic control 
of T2DM could be accounted for by the greater weight loss 
and by a larger contribution of weight­loss­independent 
mechanisms[43­45].
In our opinion, the main limitations of this study are 
the sample size of the series and the heterogeneity of 
the patients included in the series, precluding to discover 
significant differences between subgroups of patients (for 
example, only 15 super­obese patients are included in 
this series). In addition, only 32% (51/156) of patients 
reached 5­years of follow­up. The lack of adherence to 
follow­up was reported previously, and it can be related 
to several issues, including the distance to the medical 
office and a lack of trust or rapport with the surgeon or 
the medical team[46]. However, the most relevant strength 
of this study is that all patients underwent a standardized 
LSG operative technique, first, because surgeon expertise 
is a key issue to lower the complications rate[13,24] and 
second, because there were no technical differences that 
may influence the weight loss results. We always tried to 
perform a more restrictive LSG by using a thinner bougie 
and beginning the dissection 3 cm from the pylorus to 
achieve greater weight loss, as suggested by Baltasar et 
al[8,31]. In addition, the long­term follow­up of the patients 
was always carried out by the same surgeon who per­
formed the procedure.
In conclusion, a LSG built with a narrow 34 F bougie 
and starting 3 cm from the pylorus, proved to be safe 
and highly effective in terms of weight loss as a stand­
alone procedure, especially in patients with preoperative 
BMI lower than 40 kg/m2. In our opinion, LSG could be 
accepted as the first stand-alone procedure for morbidly 
obese patients with low BMI. Prospective randomized 
trials analysing long­term results (beyond ten years of 
follow­up) will help elucidate whether LSG is comparable 
to more aggressive techniques.
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